0
0
NEW DELHI, April 21, 2025 – A recent study published in the Journal of Heart and Lung Transplantation reveals a significant link between iron deficiency (ID) and poorer outcomes in children diagnosed with dilated cardiomyopathy (DCM), a condition where the heart’s main pumping chamber is enlarged and weakened.
The research highlights that iron deficiency is prevalent among these young patients but often goes unmeasured in clinical settings. The study strongly associates ID with the development of severe heart failure and an increased risk of composite adverse events (CAE), defined as requiring mechanical circulatory support (MCS), undergoing a heart transplant, or death.
Conducted as a retrospective review at a single medical center, the study examined records of all children diagnosed with DCM between 2010 and 2020 who had undergone comprehensive iron studies. Iron deficiency was identified if a patient met two or more specific criteria: ferritin levels below 20 μg/liter, transferrin above 3 g/liter, iron levels under 9 μmol/liter, or transferrin saturation (TSat) less than 15%. Researchers compared laboratory results, clinical outcomes, and the time until a composite adverse event occurred between children with and without iron deficiency.
The results showed that out of 138 children identified with DCM, complete iron studies were available for only 47. Alarmingly, within this group, 62% were found to be iron deficient.
The study found significant differences in treatment intensity and outcomes. Children with ID were considerably more likely to require potent heart medications known as inotropes (59% of ID patients) or need support from invasive or non-invasive ventilation (45% of ID patients) compared to those without ID.
Furthermore, the research indicated that nearly two-thirds of the children with measured iron levels who were iron deficient faced a significantly higher risk over time of needing MCS, a heart transplant, or succumbing to their condition. These children also typically experienced longer hospital stays. Blood tests revealed they often had characteristics of microcytic anemia (smaller than normal red blood cells) and hypochromia (paler red blood cells), alongside elevated levels of NT-proBNP, a marker indicating heart stress.
Crucially, when analyzing factors predicting poor outcomes, univariate Cox regression analysis identified iron deficiency and anemia as the only significant predictors of the composite adverse event (MCS, death, or transplant).
These findings strongly suggest that iron status should be routinely assessed in children with DCM and heart failure. The researchers propose that iron replacement therapy could be a potential treatment strategy to consider for improving outcomes in this vulnerable patient population.
Disclaimer: This news report is based on findings from a single study published in the Journal of Heart and Lung Transplantation. It is intended for informational purposes only and does not constitute medical advice. Medical decisions, including diagnosis and treatment, should always be made in consultation with qualified healthcare professionals who can assess individual patient needs and medical history. Further research may be necessary to validate these findings and establish definitive clinical guidelines.
